Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens 2011; 20: 133–138. 14 Mendelsohn ME, Karas RH. Rapid progress for non-nuclear estrogen receptor signal- ing. J Clin Invest 2010; 120: 2277–2279. 15 Yamakawa-Kobayashi K, Somekawa Y, Fujimura M, ...
Perhaps the women most at risk for blood clots are those that have been placed on hormone replacement therapy (HRT). Arecent review of datafrom several studies found that women taking hormone replacement therapy were at an increased risk of blood clot and stroke. Worse yet, women with FVL wh...
Interfering peaks which co-elute with the analytes of interest can cause ionization suppression, thus impairing detection sensitivity49. We estimated this matrix effect (ME) by comparing analyte MS/MS response in a MeOH solution and a pooled plasma extract, obtaining similar behaviors, with results...
Some clinical studies showed proteinuria reduction in patients with diabetes and hypertension [156] and slowing progression of CKD in postmenopausal women on estrogen hormone replacement therapy, which was attributed to an in-crease in renal NO production and a decrease in oxidative stress [157]. ...